Patent · US Active

Treatment of chronic ulcers

US11191810B2 · kind B2 · utility

2Cited by

11References

24Claims

0Family size

Assignee

Promore Pharma AB · SE

Inventors

Alvar Grönberg · Knivsta, SE
Christine Dieterich · Solna, SE
Margit Mahlapuu · Gothenburg, SE

Key dates

Filing date	Jun 4, 2020
Grant date	Dec 7, 2021
Priority date	—
Expiry date	Jun 4, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L2300/412
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a pharmaceutical formulation comprising LL-37 or a pharmaceutically-acceptable salt thereof and one or more pharmaceutically-acceptable diluent or carrier system, for use in a method of treatment of a chronic ulcer wound (such as a hard-to-heal venous leg ulcer or a diabetic foot ulcer), which method comprises:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.